Evidence map›Paper›PMID 24972080›Full record

ArticlePloS one2014

Recombinations in staphylococcal cassette chromosome mec elements compromise the molecular detection of methicillin resistance in Staphylococcus aureus.

Grant A Hill-Cawthorne, Lyndsey O Hudson, Moataz Fouad Abd El Ghany, Olaf Piepenburg, Mridul Nair, Andrew Dodgson, Matthew S Forrest, Taane G Clark, Arnab Pain

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of SCCAntimicrobial agents and chemotherapy · 2022
    Article
  4. Detection of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Recent advances in PCR-free nucleic acid detection for SARS-COV-2.Frontiers in bioengineering and biotechnology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Investigation of Plasmids Among ClinicalFrontiers in microbiology · 2021
    Article
  11. Rapid Detection and Differentiation ofFrontiers in chemistry · 2021
    Article
  12. Article
  13. An epidemic CC1-MRSA-IV clone yields false-negative test results in molecular MRSA identification assays: a note of caution, Austria, Germany, Ireland, 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Grant A Hill-CawthornePathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia; Marie Bashir Institute for Infectious Diseases and Biosecurity and Sydney School of Public Health, University of Sydney, Sydney, Australia.
Lyndsey O HudsonDepartment of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Moataz Fouad Abd El GhanyPathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Olaf PiepenburgTwistDx Ltd., Babraham, United Kingdom.
Mridul NairPathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Andrew DodgsonMicrobiology Dept, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Matthew S ForrestTwistDx Ltd., Babraham, United Kingdom.
Taane G ClarkDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Arnab PainPathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
King Abdullah University of Science and Technology · SATwistDx (United Kingdom) · GBImperial College London · GBLondon School of Hygiene & Tropical Medicine · GBTaronga Conservation Society Australia · AU

Funding

Biotechnology and Biological Sciences Research Council BB/D52637X/1Wellcome TrustWellcome Trust 096249/Z/11/B
6 · The paper itself

Abstract

Clinical laboratories are increasingly using molecular tests for methicillin-resistant Staphylococcus aureus (MRSA) screening. However, primers have to be targeted to a variable chromosomal region, the staphylococcal cassette chromosome mec (SCCmec). We initially screened 726 MRSA isolates from a single UK hospital trust by recombinase polymerase amplification (RPA), a novel, isothermal alternative to PCR. Undetected isolates were further characterised using multilocus sequence, spa typing and whole genome sequencing. 96% of our tested phenotypically MRSA isolates contained one of the six orfX-SCCmec junctions our RPA test and commercially available molecular tests target. However 30 isolates could not be detected. Sequencing of 24 of these isolates demonstrated recombinations within the SCCmec element with novel insertions that interfered with the RPA, preventing identification as MRSA. This result suggests that clinical laboratories cannot rely solely upon molecular assays to reliably detect all methicillin-resistance. The presence of significant recombinations in the SCCmec element, where the majority of assays target their primers, suggests that there will continue to be isolates that escape identification. We caution that dependence on amplification-based molecular assays will continue to result in failure to diagnose a small proportion (∼4%) of MRSA isolates, unless the true level of SCCmec natural diversity is determined by whole genome sequencing of a large collection of MRSA isolates.

Indexed as

Recombination, GeneticBase SequenceChromosomes, BacterialMethicillin ResistanceMethicillin-Resistant Staphylococcus aureusMolecular Diagnostic TechniquesMolecular Sequence DataMultiplex Polymerase Chain ReactionSensitivity and Specificity

Identifiers

PMID24972080
PMCPMC4074205
OpenAlexW1991740702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.